OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
82
Results
Show all
Save search
Copy query
Show results for
Unknown
(79)
Proteomics
(3)
Organisms
Homo sapiens
(2)
Mus musculus
(1)
Repository
pride
(3)
Tissue
Brain
(1)
Cell culture
(1)
Malignant cell
(1)
T cell
(1)
Disease
Ewing sarcoma of bone
(1)
Technology Type
Mass Spectrometry
(3)
Shotgun proteomics
(2)
Bottom-up proteomics
(1)
Publication Date
2026
(1)
2025
(1)
2021
(1)
Release Date
2024
(12)
2021
(10)
2022
(9)
2020
(9)
2023
(7)
2025
(5)
2018
(4)
2015
(4)
2012
(4)
2016
(3)
2014
(3)
2026
(2)
2017
(2)
2011
(2)
2019
(1)
2010
(1)
2005
(1)
Lab affiliation
Department of Fundamental Neurosciences (DNF) University of Lausanne Rue du Bugnon 9 CH-1005 Lausanne Switzerland
(1)
Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Infection and Immunity Program Room 214, level 2, 15 Innovation Walk Monash Biomedicine Discovery Institute Monash University, Clayton Campus Clayton 3800 Victoria Australia
(1)
Parker Institute for Cancer Immunotherapy, Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, South Pavilion Tower, Building 421, Rm 8-103 3400 Civic Center Blvd. Philadelphia, PA 19104-5157
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.
Not available
S-EPMC10927528
|
biostudies-literature
Cite
Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling.
Not available
S-EPMC3411518
|
biostudies-literature
Cite
Metabolic network analysis of Streptomyces tenebrarius, a Streptomyces species with an active entner-doudoroff pathway.
Not available
S-EPMC1087532
|
biostudies-literature
Cite
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
Not available
S-EPMC4133482
|
biostudies-literature
Cite
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study.
Not available
S-EPMC7375514
|
biostudies-literature
Cite
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma.
Not available
S-EPMC9833675
|
biostudies-literature
Cite
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells.
Not available
S-EPMC10041166
|
biostudies-literature
Cite
ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells.
Not available
S-EPMC10850500
|
biostudies-literature
Cite
Psychotherapy Process Dynamics and Their Relation to Treatment Success Do Not Differ Across Diagnoses.
Not available
S-EPMC12811794
|
biostudies-literature
Cite
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18.
Not available
S-EPMC6002762
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
